Skip to Main Content

Paper Details

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
JAMA Netw Open
3
2022
Author NameAffiliation
Lama GhaziClinical and Translational Research Accelerator, Yale University School of Medicine
Robert Nick BryanPerelman School of Medicine, University of Pennsylvania
William S WeintraubMedStar Health Research Institute and Georgetown University
Jeff D WilliamsonSticht Center for Healthy Aging and Alzheimer's Prevention, Wake Forest University School of Medicine
  • 1 - 4

Datasets

Release 1.2